Heavy Pharmaceutical Holdings: An indicative announcement on the holding of the 3rd Extraordinary General Meeting of Shareholders in 2024
Heavy Pharmaceutical Holdings: Announcement on the foreign issuance of perpetual bonds by holding subsidiaries
Heavy Pharmaceutical Holdings: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Heavy Pharmaceuticals Holdings: Anti-Fraud and Whistleblower Management System
Heavy Pharmaceutical Holdings: Announcement on the adjustment of guarantee amounts for holding subsidiaries
Heavy Pharmaceutical Holdings: Announcement of Resolutions of the 28th Meeting of the Eighth Board of Supervisors
Heavy Pharmaceutical Holdings: Announcement of Resolutions of the 7th Meeting of the 9th Board of Directors
Heavy Pharmaceutical Holdings: Investor Relations Activity Record Form for September 13, 2024
Heavy Pharmaceutical Holdings: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Heavy Pharmaceutical Holdings: Lawyers from Beijing Jingtian Gongcheng Law Firm on the 2024 Second Extraordinary Shareholders\' Meeting of Heavy Pharmaceutical Holdings Co., Ltd. witnessed the legal opinion
Heavy Pharmaceutical Holdings: Prompt Announcement on Convening the Second Extraordinary Shareholders\' Meeting in 2024
C.Q. Pharmaceutical Holding: Announcement of the results of the fourth tranche of midterm notes issued by the holding subsidiary for the year 2024.
C.Q. Pharmaceutical Holding: Regulations on Guarantee Management
C.Q. Pharmaceutical Holding: Announcement of Board of Directors' resolution for semi-annual report.
C.Q. Pharmaceutical Holding: Announcement Regarding Proposed Change of Company Director
C.Q. Pharmaceutical Holding: Announcement on the provision of impairment reserves in the first half of 2024
C.Q. Pharmaceutical Holding: Risk continuous assessment report about Chongqing Chemical & Pharmaceutical Holding Co., Ltd. Finance Limited.
C.Q. Pharmaceutical Holding: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
C.Q. Pharmaceutical Holding: Action plan for double improvement of quality and return
C.Q. Pharmaceutical Holding: Half-year report for the year 2024.
No Data
No Data